skip to content

Department of Chemical Engineering and Biotechnology


The Department welcomes enquiries from industry, and others, about possible collaborations to tackle particular problems or research areas, whether these are suited to a short consultancy, a small experimental programme or to a longer term study requiring a major research effort. A particular feature of this Department is that staff members are always willing to form multi-disciplinary teams, with the relevant skills, which can be brought to bear on the problem of interest.

Many organisations have found that a partnership with the Department is the most effective way to help improve their scientific skills or understanding of specialist processes, to develop and test ideas for new products and manufacturing techniques, or to optimise, modernise and enhance existing systems. We offer flexible funding, intellectual property ownership, timing, personnel and management options to suit our client companies. Projects can either be funded directly, or a range of options exist whereby industrial effort, in cash or kind, is substantially leveraged by public funding. We also have the ability to locate and consult other experts within the University of Cambridge or elsewhere in academia, as needed.

Industrial collaboration has been an enduring strength of CEB, with ongoing partnerships with blue-chip companies including Schlumberger Gould Research, ExxonMobil, BP, BorgWarner, BASF, Boeing, Bayer and AstraZeneca. The Department has a long and distinguished record of developing innovative new science and its applications via industrial secondments, international outreach and influence, independent entrepreneurs, new lecturers with industrial experience and major University-wide partnerships, including for example with Nokia, Unilever, BP, Schlumberger, TATA and Boeing.

We are keenly aware of the need to manage projects carefully, so as to ensure that agreed objectives are achieved within the time and cost specified and the required reporting arrangements at specified milestones are satisfactory. We agree safeguards with regard to the handling of confidential information and we manage the ownership of intellectual property from the outset of projects.


Latest news

Dr Hirak Patra to join UCL as Associate Professor

3 April 2020

Hirak Patra, a senior researcher in our Biosystems Engineering group, is to become Associate Professor in Nanomedicine and Regenerative Medicine at UCL.

'Green' production of magnetic silica beads wins Twitter poster prize and is our highlighted paper this month

3 April 2020

David Brossault, PhD student in our Colloidal Dispersions Group presented his recent work developing a green method to produce metal doped...

MOF homing capsule targets central powerhouse of cancer cells

2 April 2020

Researchers from our department have shown how metal-organic frameworks could target drug delivery to mitochondria in cancer cells, knocking out their central powerhouses and inducing rapid cell death, while drastically reducing the required drug dose.